Julia Stingl

23.0k citations
212 papers · 12.0k · 6 hit papers · h-index 47

Impact in

  • Oncology top 0.2%
    • Cancer Cells and Metastasis
    • Cancer-related Molecular Pathways
  • Pharmacology top 0.05%
    • Pharmacogenetics and Drug Metabolism

Papers in

    • Cancer Cells and Metastasis 31
    • Colorectal Cancer Treatments and Studies 7
    • Drug Transport and Resistance Mechanisms 7
    • Pharmacogenetics and Drug Metabolism 48

Julia Stingl

203 papers receiving 11.8k citations

Julia Stingl's Hit Papers

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update 2016 · 458 citations
4580+6+13Years since publication50010001.5k

Peers

Julia Stingl
Comparison fields: 5 of 158
  • Oncology 5.2k
  • Pharmacology 1.7k
  • Cancer Research 1.6k
  • Biological Psychiatry 189
  • Molecular Biology 4.6k
Replace James K. Liao with:
James K. Liao United States
Margaret Warner Sweden
Raymond C. Harris United States
David A. Geller United States
Hironobu Sasano Japan
Michiaki Kubo Japan
Dao Wen Wang China
Paul van der Valk Netherlands
Fred C.G.J. Sweep Netherlands
Ferdinando Nicoletti Italy
Julia Stingl relative to James K. Liao United States James K. Liao's profile →
Citations per field
00.5×2.9×
James K. Liao · 1×
Citations per year

Countries citing papers authored by Julia Stingl

Since Specialization
Citations

This map shows the geographic impact of Julia Stingl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Stingl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Stingl more than expected).

Fields of papers citing papers by Julia Stingl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Stingl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Stingl. The network helps show where Julia Stingl may publish in the future.

Co-authors

The 25 scholars most cited alongside Julia Stingl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Julia Stingl Line = papers co-authored together Julia Stingl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Generation of a functional mammary gland from a single stem cell
Hit paper breakdown →
20061527
2
Purification and unique properties of mammary epithelial stem cells
Hit paper breakdown →
20061213
3
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
Hit paper breakdown →
2015678
4
Progesterone induces adult mammary stem cell expansion
Hit paper breakdown →
2010509
5
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
Hit paper breakdown →
2016458
6
Mammary stem cells and the differentiation hierarchy: current status and perspectives
Hit paper breakdown →
2014400
7 2007359
8 2013326
9 2015325
10 2001284
11 2013274
12 2008273
13 2008249
14 2012227
15 2006219
16 1998189
17 2014173
18 2013158
19 2013140
20 2008125

About Julia Stingl

Julia Stingl is a scholar working on Oncology, Pharmacology, Molecular Biology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 212 papers that have together received 12.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (48 papers), Cancer Cells and Metastasis (31 papers), Pharmacovigilance and Adverse Drug Reactions (13 papers), Pharmaceutical studies and practices (12 papers), Pharmacological Effects and Toxicity Studies (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmaceutical Practices and Patient Outcomes (7 papers). The work is most often cited by research in Oncology (5.2k citations), Pharmacology (1.7k citations), Cancer Research (1.6k citations), Biological Psychiatry (189 citations) and Molecular Biology (4.6k citations). Julia Stingl has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Connie J. Eaves, Jane E. Visvader, Mark Shackleton, François Vaillant, Carlos Caldas, Peter Eirew, Joanne T. Emerman, Geoffrey J. Lindeman, Marie-Liesse Asselin-Labat and Li Wu. Their work appears in journals such as Pharmacogenomics, PLoS ONE, British Journal of Clinical Pharmacology, Breast Cancer Research and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact